Alpha Teknova (NASDAQ:TKNO) Now Covered by Analysts at Craig Hallum

Stock analysts at Craig Hallum started coverage on shares of Alpha Teknova (NASDAQ:TKNO) in a research report issued on Monday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. Craig Hallum’s target price would indicate a potential upside of 39.53% from the stock’s current price.

Alpha Teknova Price Performance

NASDAQ:TKNO opened at $8.60 on Monday. The stock’s 50-day simple moving average is $8.48 and its 200 day simple moving average is $6.53. Alpha Teknova has a 52-week low of $1.15 and a 52-week high of $10.37. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. The company has a market cap of $458.47 million, a P/E ratio of -11.62 and a beta of 0.34.

Institutional Investors Weigh In On Alpha Teknova

Several large investors have recently made changes to their positions in the stock. Mount Lucas Management LP acquired a new position in Alpha Teknova during the fourth quarter worth $75,000. China Universal Asset Management Co. Ltd. bought a new position in shares of Alpha Teknova in the 4th quarter valued at about $94,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in shares of Alpha Teknova during the 4th quarter worth about $180,000. Whalen Wealth Management Inc. bought a new stake in shares of Alpha Teknova in the 4th quarter valued at about $240,000. Finally, Geode Capital Management LLC lifted its stake in Alpha Teknova by 24.4% in the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after purchasing an additional 36,914 shares during the last quarter. Institutional investors and hedge funds own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.